209 related articles for article (PubMed ID: 30073422)
21. A follow-up survey of patients with acquired angioedema due to C1-inhibitor deficiency.
Pólai Z; Balla Z; Andrási N; Kőhalmi KV; Temesszentandrási G; Benedek S; Varga L; Farkas H
J Intern Med; 2021 Apr; 289(4):547-558. PubMed ID: 33215769
[TBL] [Abstract][Full Text] [Related]
22. C1-inhibitor/C1-inhibitor antibody complexes in acquired angioedema due to C1-inhibitor deficiency.
Polai Z; Kajdacsi E; Cervenak L; Balla Z; Benedek S; Varga L; Farkas H
Orphanet J Rare Dis; 2023 Feb; 18(1):24. PubMed ID: 36726161
[TBL] [Abstract][Full Text] [Related]
23. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
24. Acquired C1 esterase inhibitor deficiency in lymphomas: prevalence, symptoms, and response to treatment.
Bekos C; Perkmann T; Krauth M; Raderer M; Lechner K; Jaeger U
Leuk Lymphoma; 2016 Sep; 57(9):2033-6. PubMed ID: 26795750
[TBL] [Abstract][Full Text] [Related]
25. The acquired C1-INH deficiencies with autoantibodies (AAE type II).
Alsenz J; Loos M
Behring Inst Mitt; 1989 Jul; (84):165-72. PubMed ID: 2679532
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
[TBL] [Abstract][Full Text] [Related]
27. Ecallantide for treatment of acute attacks of acquired C1 esterase inhibitor deficiency.
Patel NS; Fung SM; Zanichelli A; Cicardi M; Cohn JR
Allergy Asthma Proc; 2013; 34(1):72-7. PubMed ID: 23406939
[TBL] [Abstract][Full Text] [Related]
28. C-1-inhibitor binding monoclonal immunoglobins in three patients with acquired angioneurotic edema.
Chevailler A; Arlaud G; Ponard D; Pernollet M; Carrère F; Renier G; Drouet M; Hurez D; Gardais J
J Allergy Clin Immunol; 1996 Apr; 97(4):998-1008. PubMed ID: 8655897
[TBL] [Abstract][Full Text] [Related]
29. Lymphoma-associated paraneoplastic angioedema with normal C1-inhibitor activity: does danazol work?
Gaur S; Cooley J; Aish L; Weinstein R
Am J Hematol; 2004 Nov; 77(3):296-8. PubMed ID: 15495244
[TBL] [Abstract][Full Text] [Related]
30. A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients.
Gobert D; Paule R; Ponard D; Levy P; Frémeaux-Bacchi V; Bouillet L; Boccon-Gibod I; Drouet C; Gayet S; Launay D; Martin L; Mekinian A; Leblond V; Fain O
Medicine (Baltimore); 2016 Aug; 95(33):e4363. PubMed ID: 27537564
[TBL] [Abstract][Full Text] [Related]
31. Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema.
Loffredo S; Bova M; Suffritti C; Borriello F; Zanichelli A; Petraroli A; Varricchi G; Triggiani M; Cicardi M; Marone G
Allergy; 2016 Jul; 71(7):989-96. PubMed ID: 26873113
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of C1-inhibitor deficiency.
Pappalardo E; Zingale LC; Terlizzi A; Zanichelli A; Folcioni A; Cicardi M
Immunobiology; 2002 Sep; 205(4-5):542-51. PubMed ID: 12396014
[TBL] [Abstract][Full Text] [Related]
33. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus.
Cacoub P; Frémeaux-Bacchi V; De Lacroix I; Guillien F; Kahn MF; Kazatchkine MD; Godeau P; Piette JC
Arthritis Rheum; 2001 Aug; 44(8):1836-40. PubMed ID: 11508436
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
[TBL] [Abstract][Full Text] [Related]
35. Genetic test indications and interpretations in patients with hereditary angioedema.
Weiler CR; van Dellen RG
Mayo Clin Proc; 2006 Jul; 81(7):958-72. PubMed ID: 16835976
[TBL] [Abstract][Full Text] [Related]
36. Shortened Activated Partial Thromboplastin Time May Help in Diagnosing Hereditary and Acquired Angioedema.
Bork K; Witzke G
Int Arch Allergy Immunol; 2016; 170(2):101-7. PubMed ID: 27463190
[TBL] [Abstract][Full Text] [Related]
37. Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency.
Cugno M; Zanichelli A; Bellatorre AG; Griffini S; Cicardi M
Allergy; 2009 Feb; 64(2):254-7. PubMed ID: 19076541
[TBL] [Abstract][Full Text] [Related]
38. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
39. Angioedema Due to Acquired Deficiency of C1-Inhibitor: A Cohort Study in Spain and a Comparison With Other Series.
Baeza ML; González-Quevedo T; Caballero T; Guilarte M; Lleonart R; Varela S; Castro M; Díaz C; Escudero E; García MG; Laffond E; Muñoz-Bellido FJ; Núñez R; Prior N; Sala-Cunill A; Sáenz de San Pedro B; Prieto-García A
J Allergy Clin Immunol Pract; 2022 Apr; 10(4):1020-1028. PubMed ID: 34844023
[TBL] [Abstract][Full Text] [Related]
40. ELISA to measure neutralizing capacity of anti-C1-inhibitor antibodies in plasma of angioedema patients.
Engel R; Rensink I; Roem D; Brouwer M; Kalei A; Perry D; Zeerleder S; Wouters D; Hamann D
J Immunol Methods; 2015 Nov; 426():114-9. PubMed ID: 26318839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
